BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9110148)

  • 1. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
    Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
    Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
    Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
    Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
    Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
    Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
    Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex.
    Port MD; Gibson RM; Nathanson NM
    J Neurochem; 2007 May; 101(3):782-93. PubMed ID: 17448148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
    Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytokine receptor gp130: faithfully promiscuous.
    Müller-Newen G
    Sci STKE; 2003 Sep; 2003(201):PE40. PubMed ID: 14506288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
    Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
    J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
    Smith DK; Treutlein HR
    Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex.
    De Serio A; Graziani R; Laufer R; Ciliberto G; Paonessa G
    J Mol Biol; 1995 Dec; 254(5):795-800. PubMed ID: 7500350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 transsignaling: the in vivo consequences.
    Jones SA; Richards PJ; Scheller J; Rose-John S
    J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.